News Briefs

05/18/2022

Hyland’s Naturals’ new brand identity reflects focus on VMS category

Image
hyland's naturals new group teaser

Hyland’s Naturals has rebranded its look with a new campaign, identity, logo, website and media launch set to reflect its growing consumer health products portfolio and strategy focused on the vitamins, minerals and supplements category.

As part of this refresh, the company announced that it will launch more than 20 new natural wellness products in the coming year that address the growing demand for natural and effective health products.

“While our business has transformed and grown dramatically over the past several years, it became clear that our customer needs were changing and we have not evolved at the same pace; we needed to accelerate our innovation platform to meet their needs," said CEO Will Righeimer.

The new logo reflects the company’s new modern outlook, which focuses on natural wellness and family-friendly, as well as its clean approach to all products. With its new brand colors, Hyland’s Naturals focused on clean and crispy hues, specifically with the clean white backgrounds to the rich blue and green, the company said.

“The rebranding of Hyland’s Naturals reflects a change both inside the company and out, with a strategy focused on innovation and expanding our consumer health category leadership while building upon our rich history and significant brand awareness,” Righeimer said.

Advertisement
05/18/2022

Swiss Miss, Cinnamon Toast Crunch add a touch of sweetness to hot drink mixes

Image
Swiss Miss Cinnamon Toast Crunch Cinnamilk

Fans of the cinnamon-flavored milk found at the bottom of cereal bowls will be reaching for a new hot drink mix from Swiss Miss and Cinnamon Toast Crunch.

The new Swiss Miss Cinnamon Toast Crunch Cinnamilk is a hot drink mix that contains Cinnamon Toast Crunch Cinnadust, marshmallows and a creamy Swiss Miss base, the Chicago-based company said.

“We love creating sweet, warm moments of indulgence,” said Audrey Ingersoll, vice president/general manager of sweet snacks at Conagra Brands. “Our new Swiss Miss Cinnamon Toast Crunch Cinnamilk hot drink mix is another delicious way for Swiss Miss to deliver happiness in a mug.”

To prepare a serving of the drink mix, consumers simply need to combine hot water with the mix and then stir in the second envelope containing the Cinnadust and marshmallows.

“We know the Cinnamilk left at the bottom of a cereal bowl is one of our fans’ favorite parts about the product,” said Astrid Perez Martin, senior brand manager for Cinnamon Toast Crunch at General Mills. “This is why we're delighted to partner with Swiss Miss to create a delicious new beverage that gives our fans a unique way to experience the unmistakable Cinnadust-flavored milk during new parts of their day.”

Each box of Swiss Miss Cinnamon Toast Crunch Cinnamilk, which includes six pairs of drink mix, will be available at e-commerce outlets, grocery stores and mass retailers for the suggested retail price of $2.99.

05/18/2022

APhA analysis finds inequity in COVID-19 test to treat access 

Image
covid-19 care

The American Pharmacists Association released the results of a new analysis showing that underserved and vulnerable communities do not have equitable access to care from COVID-19 test to treat sites, including lifesaving COVID-19 oral antivirals.   

As of May 6, 2022, when APhA conducted the analysis, there were slightly over 2,300 test to treat sites, yet there are more than 70,000 community pharmacies in the country. The analysis found that only 22% (513) of the test to treat sites are in the most vulnerable areas in the country as defined by the Social Vulnerability Index. Additionally, only 30% (< 700) of test to treat sites are in medically underserved areas of the U.S.

Although the Department of Health and Human Services has recognized the high level of training pharmacists receive by authorizing pharmacists to prescribe COVID-19 therapeutics, FDA’s emergency use authorizations for oral COVID-19 antivirals specifically exclude pharmacists as prescribers. As a result, the majority of pharmacies cannot serve as test to treat sites. These medications are being underutilized and sitting on pharmacy shelves, which unnecessarily increases healthcare costs and puts lives at risk, APhA said.

APhA said that it is urging the federal government to include our nation’s pharmacists as prescribers of oral COVID-19 antivirals to significantly increase equitable access to test to treat pharmacies by opening the door to communities that need it the most.

More information about APhA’s analysis can be found here.

Advertisement
05/17/2022

Nautica turns eco-conscious with alcohol-free fragrance

Image
Nautica Oceans Pacific Coast

Nautica has dropped a brand-new fragrance that is better for the planet.

Inspired by life on the water, Nautica Oceans Pacific Coast is designed for the man who wants to make eco-conscious purchases without having to sacrifice fragrance and grooming standards, the company said.

The clean and vegan eau de toilette is water-based, free of alcohol, and provides a non-drying and long-lasting scent. The fragrance comes in recyclable packaging, including a 25% PCR glass bottle with a removable pump, 90% PCR plastic cap and water-based ink to reduce environmental impact.

Created with fresh scents to capture the essence and energy of the Pacific Ocean, the fragrance’s sunlight zone contains wild coastal mint, white pepper and oyster leaf notes.

The twilight zone of the fragrance features stone pine, lavender and geranium scents, and the midnight zone has patchouli, Sulawesi, drift pinewood and tonka bean notes.

Available in an eau de toilette that retails for $39.99 and deodorizing body spray that retails for $9.99, Nautica Oceans Pacific Coast can be found at national retailers including Walgreens, Walmart and Amazon.

05/16/2022

AAM elevates Craig Burton

Image
craig burton

The Association for Accessible Medicines and its board of directors has promoted Craig Burton to senior vice president of policy and strategic alliances, effective May 30, 2022.

Burton also will become the executive director of the Biosimilars Council, which is the preeminent voice advocating in Washington and the states for policies to improve access to more affordable alternatives to expensive biologic medicines.

With more than 20 years of federal health policy experience, Burton has served in key roles at the center of a range of pressing healthcare debates. Prior to joining AAM in 2017, he was at Avalere Health, where he helped clients anticipate and plan for the impact of change stemming from legislative, regulatory or other market dynamics. He also established and directed the health policy and government relations efforts at two biopharmaceutical companies.

“The AAM board and I are pleased to elevate Craig to senior vice president, where he will continue his work to create and promote policy solutions to ensure that America’s patients have access to the safe, affordable and effective generic and biosimilar medicines that they depend on,” said Dan Leonard, AAM president and CEO. “Craig is nationally recognized as a leading expert in health policy, and his experience in both the executive and legislative branches of government makes him an invaluable advocate for our industry and the patients that it serves.”

Burton also served as deputy assistant secretary for legislation in the U.S. Department of Health and Human Services. In this role, he advised the secretary, senior department leaders and White House officials on legislative strategy to achieve key priorities. He also served in the Senate, where he was health policy advisor to Senate majority leader Bill Frist, and as professional staff on the U.S. Senate Committee on Health, Education, Labor and Pensions.

AAM's long-time executive vice president of policy and head of the Biosimilars Council, Christine Simmon, has just been named president and CEO of the Food and Drug Law Institute, the nonprofit membership organization that offers education, training, publications and professional engagement opportunities in the field of food and drug law.

05/16/2022

Camber intros generic Atripla

Image
a close up of a toy

Camber is offering efavirenz, emtricitabine and tenofovir disoproxil fumarate tablets.

The medication, which is a generic of Gilead's Atripla, is indicated as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 88 lbs.

Camber’s generic product is available in 600 mg, 200 mg and 300 mg 30-count bottles.